Sofia, Bulgaria

Jossif N Nissimov

This inventor holds 1 USPTO granted patent. Top assignee: Pharmachim. Active years: 1990.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jossif N Nissimov. Retrieved from https://idiyas.com/inventor/jossif-n-nissimov

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 15.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1990

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jossif N Nissimov: Innovator in Glaucoma Treatment

Introduction

Jossif N Nissimov is a notable inventor based in Sofia, Bulgaria. He has made significant contributions to the field of ophthalmology, particularly in the treatment of glaucoma. His innovative approach has led to the development of a unique antiglaucoma composition.

Latest Patents

Jossif N Nissimov holds 1 patent for his invention titled "Composition and method for treating glaucoma." This patent describes an antiglaucoma composition that contains as the active component a s-/-/-2,3 dihydroxy-9,10,11-trimethoxy-5,8,13,13a-tetrahydro-6H-dibenzo (a,f) quinolizine hydrochloride. The composition is formulated for use as an ophthalmic solution, which is administered in therapeutic doses of 2 to 3 drops two to four times daily to treat glaucoma in warm-blooded animals.

Career Highlights

Jossif N Nissimov is associated with Pharmachim, a company known for its pharmaceutical innovations. His work at Pharmachim has allowed him to focus on developing effective treatments for eye conditions, particularly glaucoma.

Collaborations

Some of his notable coworkers include Marko T Markov and Chavdar B Ivanov, who have contributed to the collaborative efforts in research and development within the company.

Conclusion

Jossif N Nissimov's contributions to glaucoma treatment through his innovative patent highlight his dedication to improving healthcare solutions. His work continues to impact the field of ophthalmology positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…